FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Intern Med / Probiotic use in horses – what is the evidence for the...
Journal of veterinary internal medicine2014; 28(6); 1640-1652; doi: 10.1111/jvim.12451

Probiotic use in horses – what is the evidence for their clinical efficacy?

Abstract: The gastrointestinal microbiota is extremely important for human and animal health. Investigations into the composition of the microbiota and its therapeutic modification have received increasing interest in human and veterinary medicine. Probiotics are a way of modifying the microbiota and have been tested to prevent and treat diseases. Probiotics are proposed to exert their beneficial effects through various pathways. Production of antimicrobial compounds targeting intestinal pathogens, general immune stimulation, and colonization resistance are among these mechanisms. Despite widespread availability and use, scientific, peer-reviewed evidence behind commercial probiotic formulations in horses is limited. Additionally, quality control of commercial over-the-counter products is not tightly regulated. Although promising in vitro results have been achieved, in vivo health benefits have been more difficult to prove. Whether the ambiguous results are caused by strain selection, dosage selection or true lack of efficacy remains to be answered. Although these limitations exist, probiotics are increasingly used because of their lack of severe adverse effects, ease of administration, and low cost. This review summarizes the current evidence for probiotic use in equine medicine. It aims to provide veterinarians with evidence-based information on when and why probiotics are indicated for prevention or treatment of gastrointestinal disease in horses. The review also outlines the current state of knowledge on the equine microbiota and the potential of fecal microbial transplantation, as they relate to the topic of probiotics.
Copyright © 2014 by the American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2014-09-17 PubMed ID: 25231539PubMed Central: PMC4895607DOI: 10.1111/jvim.12451Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines the use of probiotics in horses and analyzes the existing scientific evidence regarding their clinical effectiveness. Although probiotics are widely used due to their low cost and minimal side effects, the actual scientific support for their benefits in horses is limited and sometimes unclear.

Importance of Gut Microbiota

The research starts by acknowledging the vital role of gastrointestinal microbiota in both human and animal health. The microbiota aids in the digestive process, combats harmful microorganisms, and contributes positively towards the immune system. As such, any changes to it, such as the introduction of probiotics, can potentially have significant effects on health.

  • Spotlight is placed on the increasing number of research into the composition of microbiota and how it can be altered for therapeutic purposes.
  • The paper alludes to the idea that probiotics, which are live bacteria and yeasts, could be a possible way of modifying microbiota to improve health.

Potential Benefits of Probiotics

Here, the paper discusses the supposed benefits of probiotics and the mechanisms by which they are believed to exert their positive effects.

  • Probiotics are thought to produce substances that can fight off harmful pathogens in the intestines.
  • They are also considered to stimulate the immune system in general.
  • Furthermore, they are believed to inhibit harmful microorganisms from colonizing the gut, a mechanism known as colonization resistance.

Current Evidence for the Efficacy of Probiotics in Horses

The article admits that the scientific evidence backing the use of probiotics in horses is limited. Additionally, there is less stringent regulation over commercially available probiotics.

  • Promising results have been seen in vitro (under laboratory conditions), but consistent in vivo (in living organisms) results have been harder to obtain.
  • The review questions whether these discrepancies are due to the choice of bacterial strain for the probiotics, the chosen dosage, or the probiotics’ actual efficacy.
  • However, despite these uncertainties, probiotics are still commonly used due to other advantages such as being easy to administer, having minimal side effects, and being inexpensive.

Use of Probiotics in Equine Medicine

The review aims to equip veterinarians with an evidence-based understanding of when and why probiotics should be used for treating gastrointestinal diseases in horses. It examines the current state of knowledge on horses’ gut microbiota and explores the potential benefits of fecal microbial transplantation, another method of modifying gut microbiota.

Cite This Article

APA
Schoster A, Weese JS, Guardabassi L. (2014). Probiotic use in horses – what is the evidence for their clinical efficacy? J Vet Intern Med, 28(6), 1640-1652. https://doi.org/10.1111/jvim.12451

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 28
Issue: 6
Pages: 1640-1652

Researcher Affiliations

Schoster, A
  • Clinic for Equine Internal Medicine, University of Zurich, Zurich, Switzerland; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Weese, J S
    Guardabassi, L

      MeSH Terms

      • Animals
      • Gastrointestinal Tract / drug effects
      • Gastrointestinal Tract / microbiology
      • Horse Diseases / drug therapy
      • Horse Diseases / microbiology
      • Horse Diseases / prevention & control
      • Horses / microbiology
      • Microbiota / drug effects
      • Probiotics / therapeutic use

      References

      This article includes 99 references
      1. Lederberg JM, McCray A. Ome Sweet. The Scientist 2001;15:8.
      2. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M. The NIH Human Microbiome Project.. Genome Res 2009 Dec;19(12):2317-23.
        pmc: PMC2792171pubmed: 19819907doi: 10.1101/gr.096651.109google scholar: lookup
      3. Al Jassim RA, Andrews FM. The bacterial community of the horse gastrointestinal tract and its relation to fermentative acidosis, laminitis, colic, and stomach ulcers.. Vet Clin North Am Equine Pract 2009 Aug;25(2):199-215.
        pubmed: 19580934doi: 10.1016/j.cveq.2009.04.005google scholar: lookup
      4. Costa MC, Arroyo LG, Allen-Vercoe E, Stämpfli HR, Kim PT, Sturgeon A, Weese JS. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene.. PLoS One 2012;7(7):e41484.
        pmc: PMC3409227pubmed: 22859989doi: 10.1371/journal.pone.0041484google scholar: lookup
      5. Costa MC, Weese JS. The equine intestinal microbiome. Animal health research reviews/Conference of Research Workers in Animal Diseases 2012: 1–8.
      6. Friedrich MJ. Microbiome project seeks to understand human body's microscopic residents.. JAMA 2008 Aug 20;300(7):777-8.
        pubmed: 18714051doi: 10.1001/jama.300.7.777google scholar: lookup
      7. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.. Proc Natl Acad Sci U S A 2007 Aug 21;104(34):13780-5.
        pmc: PMC1959459pubmed: 17699621doi: 10.1073/pnas.0706625104google scholar: lookup
      8. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.. PLoS One 2010 Feb 5;5(2):e9085.
        pmc: PMC2816710pubmed: 20140211doi: 10.1371/journal.pone.0009085google scholar: lookup
      9. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.. Nature 2011 Apr 7;472(7341):57-63.
        pmc: PMC3086762pubmed: 21475195doi: 10.1038/nature09922google scholar: lookup
      10. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis.. Nat Rev Rheumatol 2011 Aug 23;7(10):569-78.
        pmc: PMC3275101pubmed: 21862983doi: 10.1038/nrrheum.2011.121google scholar: lookup
      11. Båverud V, Gustafsson A, Franklin A, Lindholm A, Gunnarsson A. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics.. Equine Vet J 1997 Jul;29(4):279-84.
        pubmed: 15338908doi: 10.1111/j.2042-3306.1997.tb03124.xgoogle scholar: lookup
      12. Gustafsson A, Båverud V, Gunnarsson A, Rantzien MH, Lindholm A, Franklin A. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden.. Equine Vet J 1997 Jul;29(4):314-8.
        pubmed: 15338913doi: 10.1111/j.2042-3306.1997.tb03129.xgoogle scholar: lookup
      13. Garrett LA, Brown R, Poxton IR. A comparative study of the intestinal microbiota of healthy horses and those suffering from equine grass sickness.. Vet Microbiol 2002 Jun 5;87(1):81-8.
        pubmed: 12079749doi: 10.1016/s0378-1135(02)00018-4google scholar: lookup
      14. Milinovich GJ, Trott DJ, Burrell PC, Croser EL, Al Jassim RA, Morton JM, van Eps AW, Pollitt CC. Fluorescence in situ hybridization analysis of hindgut bacteria associated with the development of equine laminitis.. Environ Microbiol 2007 Aug;9(8):2090-100.
        pubmed: 17635552doi: 10.1111/j.1462-2920.2007.01327.xgoogle scholar: lookup
      15. Moreau MM, Eades SC, Reinemeyer CR, Fugaro MN, Onishi JC. Illumina sequencing of the V4 hypervariable region 16S rRNA gene reveals extensive changes in bacterial communities in the cecum following carbohydrate oral infusion and development of early-stage acute laminitis in the horse.. Vet Microbiol 2014 Jan 31;168(2-4):436-41.
        pubmed: 24355533doi: 10.1016/j.vetmic.2013.11.017google scholar: lookup
      16. Bailey SR, Rycroft A, Elliott J. Production of amines in equine cecal contents in an in vitro model of carbohydrate overload.. J Anim Sci 2002 Oct;80(10):2656-62.
        pubmed: 12413088doi: 10.2527/2002.80102656xgoogle scholar: lookup
      17. Medina B, Girard ID, Jacotot E, Julliand V. Effect of a preparation of Saccharomyces cerevisiae on microbial profiles and fermentation patterns in the large intestine of horses fed a high fiber or a high starch diet.. J Anim Sci 2002 Oct;80(10):2600-9.
        pubmed: 12413082doi: 10.2527/2002.80102600xgoogle scholar: lookup
      18. Milinovich GJ, Burrell PC, Pollitt CC, Klieve AV, Blackall LL, Ouwerkerk D, Woodland E, Trott DJ. Microbial ecology of the equine hindgut during oligofructose-induced laminitis.. ISME J 2008 Nov;2(11):1089-100.
        pubmed: 18580970doi: 10.1038/ismej.2008.67google scholar: lookup
      19. Milinovich GJ, Trott DJ, Burrell PC, van Eps AW, Thoefner MB, Blackall LL, Al Jassim RA, Morton JM, Pollitt CC. Changes in equine hindgut bacterial populations during oligofructose-induced laminitis.. Environ Microbiol 2006 May;8(5):885-98.
        pubmed: 16623745doi: 10.1111/j.1462-2920.2005.00975.xgoogle scholar: lookup
      20. Respondek F, Goachet AG, Julliand V. Effects of dietary short-chain fructooligosaccharides on the intestinal microflora of horses subjected to a sudden change in diet.. J Anim Sci 2008 Feb;86(2):316-23.
        pubmed: 17940163doi: 10.2527/jas.2006-782google scholar: lookup
      21. Muhonen S, Connysson M, Lindberg JE, Julliand V, Bertilsson J, Jansson A. Effects of crude protein intake from grass silage-only diets on the equine colon ecosystem after an abrupt feed change.. J Anim Sci 2008 Dec;86(12):3465-72.
        pubmed: 18676731doi: 10.2527/jas.2007-0374google scholar: lookup
      22. Muhonen S, Julliand V, Lindberg JE, Bertilsson J, Jansson A. Effects on the equine colon ecosystem of grass silage and haylage diets after an abrupt change from hay.. J Anim Sci 2009 Jul;87(7):2291-8.
        pubmed: 19329474doi: 10.2527/jas.2008-1461google scholar: lookup
      23. Shepherd ML, Swecker WS Jr, Jensen RV, Ponder MA. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons.. FEMS Microbiol Lett 2012 Jan;326(1):62-8.
        pubmed: 22092776doi: 10.1111/j.1574-6968.2011.02434.xgoogle scholar: lookup
      24. Dougal K, Harris PA, Edwards A, Pachebat JA, Blackmore TM, Worgan HJ, Newbold CJ. A comparison of the microbiome and the metabolome of different regions of the equine hindgut.. FEMS Microbiol Ecol 2012 Dec;82(3):642-52.
        pubmed: 22757649doi: 10.1111/j.1574-6941.2012.01441.xgoogle scholar: lookup
      25. Dougal K, de la Fuente G, Harris PA, Girdwood SE, Pinloche E, Geor RJ, Nielsen BD, Schott HC 2nd, Elzinga S, Newbold CJ. Characterisation of the faecal bacterial community in adult and elderly horses fed a high fibre, high oil or high starch diet using 454 pyrosequencing.. PLoS One 2014;9(2):e87424.
        pmc: PMC3913607pubmed: 24504261doi: 10.1371/journal.pone.0087424google scholar: lookup
      26. O' Donnell MM, Harris HM, Jeffery IB, Claesson MJ, Younge B, O' Toole PW, Ross RP. The core faecal bacterial microbiome of Irish Thoroughbred racehorses.. Lett Appl Microbiol 2013 Dec;57(6):492-501.
        pubmed: 23889584doi: 10.1111/lam.12137google scholar: lookup
      27. Dougal K, de la Fuente G, Harris PA, Girdwood SE, Pinloche E, Newbold CJ. Identification of a core bacterial community within the large intestine of the horse.. PLoS One 2013;8(10):e77660.
        pmc: PMC3812009pubmed: 24204908doi: 10.1371/journal.pone.0077660google scholar: lookup
      28. Schoster A, Arroyo LG, Staempfli HR, Weese JS. Comparison of microbial populations in the small intestine, large intestine and feces of healthy horses using terminal restriction fragment length polymorphism.. BMC Res Notes 2013 Mar 12;6:91.
        pmc: PMC3622624pubmed: 23497580doi: 10.1186/1756-0500-6-91google scholar: lookup
      29. Metchnikoff E. Optimistic studies. New York: Putman's Sons; 1908:22.
      30. nFAO/WHOn. Working group for drafting guidelines for the evaluation of probiotics in food. ftp://ftpfaoorg/es/esn/food/wgreport2pdf 2002.
      31. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.. Immunol Cell Biol 2000 Feb;78(1):80-8.
        pubmed: 10651933doi: 10.1046/j.1440-1711.2000.00886.xgoogle scholar: lookup
      32. Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use.. J Nutr 2000 Feb;130(2S Suppl):391S-395S.
        pubmed: 10721913doi: 10.1093/jn/130.2.391sgoogle scholar: lookup
      33. Yuki N, Shimazaki T, Kushiro A, Watanabe K, Uchida K, Yuyama T, Morotomi M. Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactobacilli.. Appl Environ Microbiol 2000 Nov;66(11):5030-4.
        pmc: PMC92416pubmed: 11055960doi: 10.1128/aem.66.11.5030-5034.2000google scholar: lookup
      34. Lauková A, Simonová M, Strompfová V, Styriak I, Ouwehand AC, Várady M. Potential of enterococci isolated from horses.. Anaerobe 2008 Oct;14(4):234-6.
        pubmed: 18508395doi: 10.1016/j.anaerobe.2008.04.002google scholar: lookup
      35. Lauková A, Strompfová V, Ouwehand A. Adhesion properties of enterococci to intestinal mucus of different hosts.. Vet Res Commun 2004 Nov;28(8):647-55.
        pubmed: 15609865doi: 10.1023/b:verc.0000045948.04027.a7google scholar: lookup
      36. Rinkinen M, Westermarck E, Salminen S, Ouwehand AC. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucus.. Vet Microbiol 2003 Dec 2;97(1-2):55-61.
        pubmed: 14637038doi: 10.1016/s0378-1135(03)00183-4google scholar: lookup
      37. Schoster A, Kokotovic B, Permin A, Pedersen PD, Dal Bello F, Guardabassi L. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.. Anaerobe 2013 Apr;20:36-41.
        pubmed: 23471038doi: 10.1016/j.anaerobe.2013.02.006google scholar: lookup
      38. Gueimonde M, Sánchez B, G de Los Reyes-Gavilán C, Margolles A. Antibiotic resistance in probiotic bacteria.. Front Microbiol 2013;4:202.
        pmc: PMC3714544pubmed: 23882264doi: 10.3389/fmicb.2013.00202google scholar: lookup
      39. Bennedsen M, Stuer-Lauridsen B, Danielsen M, Johansen E. Screening for antimicrobial resistance genes and virulence factors via genome sequencing.. Appl Environ Microbiol 2011 Apr;77(8):2785-7.
        pmc: PMC3126367pubmed: 21335393doi: 10.1128/aem.02493-10google scholar: lookup
      40. Cebrián R, Baños A, Valdivia E, Pérez-Pulido R, Martínez-Bueno M, Maqueda M. Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain.. Food Microbiol 2012 May;30(1):59-67.
        pubmed: 22265284doi: 10.1016/j.fm.2011.12.002google scholar: lookup
      41. Banwo K, Sanni A, Tan H. Technological properties and probiotic potential of Enterococcus faecium strains isolated from cow milk.. J Appl Microbiol 2013 Jan;114(1):229-41.
        pubmed: 23035976doi: 10.1111/jam.12031google scholar: lookup
      42. Muñoz-Atienza E, Gómez-Sala B, Araújo C, Campanero C, del Campo R, Hernández PE, Herranz C, Cintas LM. Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture.. BMC Microbiol 2013 Jan 24;13:15.
        pmc: PMC3574848pubmed: 23347637doi: 10.1186/1471-2180-13-15google scholar: lookup
      43. Mater DD, Langella P, Corthier G, Flores MJ. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice.. J Mol Microbiol Biotechnol 2008;14(1-3):123-7.
        pubmed: 17957119doi: 10.1159/000106091google scholar: lookup
      44. Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, Klaenhammer TR. Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63.. Plasmid 1994 Jan;31(1):60-71.
        pubmed: 8171126doi: 10.1006/plas.1994.1007google scholar: lookup
      45. Vescovo M, Morelli L, Bottazzi V, Gasson MJ. Conjugal Transfer of Broad-Host-Range Plasmid pAMbeta1 into Enteric Species of Lactic Acid Bacteria.. Appl Environ Microbiol 1983 Sep;46(3):753-5.
        pmc: PMC239345pubmed: 16346389doi: 10.1128/aem.46.3.753-755.1983google scholar: lookup
      46. Weese JS, Anderson ME, Lowe A, Monteith GJ. Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.. Can Vet J 2003 Apr;44(4):299-302.
        pmc: PMC372248pubmed: 12715981
      47. Desrochers AM, Dolente BA, Roy MF, Boston R, Carlisle S. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis.. J Am Vet Med Assoc 2005 Sep 15;227(6):954-9.
        pubmed: 16190596doi: 10.2460/javma.2005.227.954google scholar: lookup
      48. Jouany JP, Gobert J, Medina B, Bertin G, Julliand V. Effect of live yeast culture supplementation on apparent digestibility and rate of passage in horses fed a high-fiber or high-starch diet.. J Anim Sci 2008 Feb;86(2):339-47.
        pubmed: 17911241doi: 10.2527/jas.2006-796google scholar: lookup
      49. Jouany JP, Medina B, Bertin G, Julliand V. Effect of live yeast culture supplementation on hindgut microbial communities and their polysaccharidase and glycoside hydrolase activities in horses fed a high-fiber or high-starch diet.. J Anim Sci 2009 Sep;87(9):2844-52.
        pubmed: 19465499doi: 10.2527/jas.2008-1602google scholar: lookup
      50. van Duijkeren E, Flemming C, Sloet van Oldruitenborgh-Oosterbaan M, Kalsbeek HC, van der Giessen JW. Diagnosing salmonellosis in horses. Culturing of multiple versus single faecal samples.. Vet Q 1995 Jun;17(2):63-6.
        pubmed: 7571282doi: 10.1080/01652176.1995.9694534google scholar: lookup
      51. Oelschlaeger TA. Mechanisms of probiotic actions - A review.. Int J Med Microbiol 2010 Jan;300(1):57-62.
        pubmed: 19783474doi: 10.1016/j.ijmm.2009.08.005google scholar: lookup
      52. Watanabe T, Nishio H, Tanigawa T, Yamagami H, Okazaki H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Asahara T, Nomoto K, Higuchi K, Takeuchi K, Arakawa T. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.. Am J Physiol Gastrointest Liver Physiol 2009 Sep;297(3):G506-13.
        pubmed: 19589943doi: 10.1152/ajpgi.90553.2008google scholar: lookup
      53. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, Hoekstra MO, de Kleer IM. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans.. Clin Exp Allergy 2010 Jan;40(1):103-10.
        pubmed: 19817754doi: 10.1111/j.1365-2222.2009.03344.xgoogle scholar: lookup
      54. Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine.. Gut Microbes 2010 May-Jun;1(3):148-63.
        pmc: PMC2909492pubmed: 20672012doi: 10.4161/gmic.1.3.11712google scholar: lookup
      55. Rinkinen M, Jalava K, Westermarck E, Salminen S, Ouwehand AC. Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization?. Vet Microbiol 2003 Mar 20;92(1-2):111-9.
        pubmed: 12488075doi: 10.1016/s0378-1135(02)00356-5google scholar: lookup
      56. He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, Knowles DM, Rescigno M, Cerutti A. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.. Immunity 2007 Jun;26(6):812-26.
        pubmed: 17570691doi: 10.1016/j.immuni.2007.04.014google scholar: lookup
      57. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children.. Int J Food Microbiol 1998 Jun 30;42(1-2):39-44.
        pubmed: 9706796doi: 10.1016/s0168-1605(98)00056-7google scholar: lookup
      58. Park JH, Um JI, Lee BJ, Goh JS, Park SY, Kim WS, Kim PH. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production.. Cell Immunol 2002 Sep;219(1):22-7.
        pubmed: 12473264doi: 10.1016/s0008-8749(02)00579-8google scholar: lookup
      59. Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties.. J Biotechnol 2000 Dec 28;84(3):197-215.
        pubmed: 11164262doi: 10.1016/s0168-1656(00)00375-8google scholar: lookup
      60. Collado MC, Grześkowiak Ł, Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa.. Curr Microbiol 2007 Sep;55(3):260-5.
        pubmed: 17657533doi: 10.1007/s00284-007-0144-8google scholar: lookup
      61. Collado MC, Meriluoto J, Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus.. Lett Appl Microbiol 2007 Oct;45(4):454-60.
        pubmed: 17897389doi: 10.1111/j.1472-765x.2007.02212.xgoogle scholar: lookup
      62. Chen X, Kokkotou EG, Mustafa N, Bhaskar KR, Sougioultzis S, O'Brien M, Pothoulakis C, Kelly CP. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis.. J Biol Chem 2006 Aug 25;281(34):24449-54.
        pubmed: 16816386doi: 10.1074/jbc.m605200200google scholar: lookup
      63. Bayoumi MA, Griffiths MW. In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules.. Int J Food Microbiol 2012 Jun 1;156(3):255-63.
        pubmed: 22541391doi: 10.1016/j.ijfoodmicro.2012.03.034google scholar: lookup
      64. Allaart JG, van Asten AJ, Vernooij JC, Gröne A. Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens.. Appl Environ Microbiol 2011 Jul;77(13):4406-11.
        pmc: PMC3127699pubmed: 21602389doi: 10.1128/aem.03002-10google scholar: lookup
      65. Medellin-Peña MJ, Wang H, Johnson R, Anand S, Griffiths MW. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7.. Appl Environ Microbiol 2007 Jul;73(13):4259-67.
        pmc: PMC1932779pubmed: 17496132doi: 10.1128/aem.00159-07google scholar: lookup
      66. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.. Infect Immun 1999 Jan;67(1):302-7.
        pmc: PMC96311pubmed: 9864230doi: 10.1128/iai.67.1.302-307.1999google scholar: lookup
      67. Gratz S, Täubel M, Juvonen RO, Viluksela M, Turner PC, Mykkänen H, El-Nezami H. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats.. Appl Environ Microbiol 2006 Nov;72(11):7398-400.
        pmc: PMC1636196pubmed: 16980432doi: 10.1128/aem.01348-06google scholar: lookup
      68. Turner PC, Wu QK, Piekkola S, Gratz S, Mykkänen H, El-Nezami H. Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol.. Food Chem Toxicol 2008 Jun;46(6):2118-23.
        pubmed: 18343010doi: 10.1016/j.fct.2008.02.004google scholar: lookup
      69. Weese JS. Evaluation of deficiencies in labeling of commercial probiotics.. Can Vet J 2003 Dec;44(12):982-3.
        pmc: PMC340366pubmed: 14703084
      70. Weese JS. Microbiologic evaluation of commercial probiotics.. J Am Vet Med Assoc 2002 Mar 15;220(6):794-7.
        pubmed: 11918274doi: 10.2460/javma.2002.220.794google scholar: lookup
      71. Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy.. Can Vet J 2011 Jan;52(1):43-6.
        pmc: PMC3003573pubmed: 21461205
      72. Ward MP, Alinovi CA, Couetil LL. A randomized clinical trial using probiotics to prevent Salmonella fecal shedding in hospitalized horses. J Equine Vet Sci 2004;24:242–247.
      73. Shanahan F. A commentary on the safety of probiotics.. Gastroenterol Clin North Am 2012 Dec;41(4):869-76.
        pubmed: 23101692doi: 10.1016/j.gtc.2012.08.006google scholar: lookup
      74. Weese JS, Anderson ME, Lowe A, Penno R, da Costa TM, Button L, Goth KC. Screening of the equine intestinal microflora for potential probiotic organisms.. Equine Vet J 2004 May;36(4):351-5.
        pubmed: 15163044doi: 10.2746/0425164044890616google scholar: lookup
      75. Weese JS, Rousseau J. Evaluation of Lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals.. J Am Vet Med Assoc 2005 Jun 15;226(12):2031-4.
        pubmed: 15989186doi: 10.2460/javma.2005.226.2031google scholar: lookup
      76. Parraga ME, Spier SJ, Thurmond M, Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the postoperative period in horses with colic.. J Vet Intern Med 1997 Jan-Feb;11(1):36-41.
        pubmed: 9132482doi: 10.1111/j.1939-1676.1997.tb00071.xgoogle scholar: lookup
      77. Boyle AG, Magdesian KG, Durando MM, Gallop R, Sigdel S. Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhoea.. Vet Rec 2013 Feb 2;172(5):128.
        pubmed: 23161811doi: 10.1136/vr.100833google scholar: lookup
      78. Earing E, Bacterial J. Colonization of the equine gut; comparison of mare and foal pairs by PCR‐DGGE. Adv Microbiol 2012;02:79–86.
      79. Yuyama T. Evaluation of a host‐specific Lactobacillus probiotic in neonatal foals. J Appl Res Vet Med 2004;2:26–32.
      80. Chioukh FZ, Ben Hmida H, Ben Ameur K, Toumi A, Monastiri K. [Saccharomyces cerevisiae fungemia in a premature neonate treated receiving probiotics].. Med Mal Infect 2013 Aug;43(8):359-60.
        pubmed: 23876201doi: 10.1016/j.medmal.2013.06.008google scholar: lookup
      81. Kim LM, Morley PS, Traub-Dargatz JL, Salman MD, Gentry-Weeks C. Factors associated with Salmonella shedding among equine colic patients at a veterinary teaching hospital.. J Am Vet Med Assoc 2001 Mar 1;218(5):740-8.
        pubmed: 11280409doi: 10.2460/javma.2001.218.740google scholar: lookup
      82. Landes AD, Hassel DM, Funk JD, Hill A. Fecal sand clearance is enhanced with a product combining probiotics, prebiotics, and psyllium in clinically normal horses. J Equine Vet Sci 2008;28:79–84.
      83. Feary DJ, Hassel DM. Enteritis and colitis in horses.. Vet Clin North Am Equine Pract 2006 Aug;22(2):437-79, ix.
        pubmed: 16882483doi: 10.1016/j.cveq.2006.03.008google scholar: lookup
      84. Frederick J, Giguère S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008).. J Vet Intern Med 2009 Nov-Dec;23(6):1254-60.
        pmc: PMC7166729pubmed: 19747192doi: 10.1111/j.1939-1676.2009.0383.xgoogle scholar: lookup
      85. Vandeplas S, Dubois Dauphin R, Beckers Y, Thonart P, Théwis A. Salmonella in chicken: current and developing strategies to reduce contamination at farm level.. J Food Prot 2010 Apr;73(4):774-85.
        pubmed: 20377971doi: 10.4315/0362-028x-73.4.774google scholar: lookup
      86. Frizzo LS, Zbrun MV, Soto LP, Bertozzi E, Sequeira GJ, Marti LE, Signorini ML, Armesto RR, Rosmini MR. Pathogen translocation and histopathological lesions in an experimental model of Salmonella Dublin infection in calves receiving lactic acid bacteria and lactose supplements.. J Vet Sci 2012 Sep;13(3):261-70.
        pmc: PMC3467401pubmed: 23000583doi: 10.4142/jvs.2012.13.3.261google scholar: lookup
      87. Ramey DW, Reinertson EL. Sand-induced diarrhea in a foal.. J Am Vet Med Assoc 1984 Sep 1;185(5):537-8.
        pubmed: 6541217
      88. Bertone JJ, Traub-Dargatz JL, Wrigley RW, Bennett DG, Williams RJ. Diarrhea associated with sand in the gastrointestinal tract of horses.. J Am Vet Med Assoc 1988 Dec 1;193(11):1409-12.
        pubmed: 3209452
      89. Hart KA, Linnenkohl W, Mayer JR, House AM, Gold JR, Giguère S. Medical management of sand enteropathy in 62 horses.. Equine Vet J 2013 Jul;45(4):465-9.
        pubmed: 23205506doi: 10.1111/evj.12014google scholar: lookup
      90. Arora T, Singh S, Sharma RK. Probiotics: Interaction with gut microbiome and antiobesity potential.. Nutrition 2013 Apr;29(4):591-6.
        pubmed: 23287068doi: 10.1016/j.nut.2012.07.017google scholar: lookup
      91. Borody TJ, Campbell J. Fecal microbiota transplantation: current status and future directions.. Expert Rev Gastroenterol Hepatol 2011 Dec;5(6):653-5.
        pubmed: 22017691doi: 10.1586/egh.11.71google scholar: lookup
      92. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.. Clin Infect Dis 2011 Nov;53(10):994-1002.
        pubmed: 22002980doi: 10.1093/cid/cir632google scholar: lookup
      93. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.. J Clin Gastroenterol 2010 May-Jun;44(5):354-60.
        pubmed: 20048681doi: 10.1097/mcg.0b013e3181c87e02google scholar: lookup
      94. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr, Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.. J Pediatr Gastroenterol Nutr 2013 Jun;56(6):597-601.
        pubmed: 23542823doi: 10.1097/mpg.0b013e318292fa0dgoogle scholar: lookup
      95. Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.. Dig Liver Dis 2002 Sep;34 Suppl 2:S48-53.
        pubmed: 12408440doi: 10.1016/s1590-8658(02)80164-5google scholar: lookup
      96. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy.. J Clin Gastroenterol 2003 Jul;37(1):42-7.
        pubmed: 12811208doi: 10.1097/00004836-200307000-00012google scholar: lookup
      97. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.. Gastroenterology 2012 Oct;143(4):913-6.e7.
        pubmed: 22728514doi: 10.1053/j.gastro.2012.06.031google scholar: lookup
      98. Guo B, Harstall C, Louie T, Veldhuyzen van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease.. Aliment Pharmacol Ther 2012 Apr;35(8):865-75.
        pubmed: 22360412doi: 10.1111/j.1365-2036.2012.05033.xgoogle scholar: lookup
      99. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora.. J Clin Gastroenterol 2010 Sep;44(8):551-61.
        pubmed: 20716985doi: 10.1097/mcg.0b013e3181e5d06bgoogle scholar: lookup

      Citations

      This article has been cited 31 times.
      Subscribe to our newsletter
      Join 99,030 horse owners like you who receive our email updates on horse health and nutrition.